MISSISSAUGA, ON, March 5, 2020 /CNW/ - Gilead Sciences Canada,
Inc. (Gilead Canada), based in
Mississauga, Ontario, today
announced the appointment of Melissa
Koomey as Vice President and General Manager. Koomey will be
responsible for leading Gilead Sciences' team across Canada.
"We are pleased to welcome Melissa as our new Vice President and
General Manager for Canada operations," said Rudolf Ertl, Senior Vice President, Commercial
Operations, Australia/Canada/Europe. "Over her more than seven years with
Gilead, Melissa has served in many leadership roles, most recently
as Vice President of the HIV Business Unit in the United States, making Melissa an
exceptional leader for our Canadian business."
Prior to her time at Gilead Sciences, Koomey held leadership
positions across therapeutic areas with several innovative
medicines companies. Koomey holds a Bachelor of Arts from
Yale College and a Master of
Business Administration from Harvard Business
School. Koomey is also a member of the Board of Directors of
the National AIDS Memorial in San
Francisco, California.
"I'm honoured to have been selected to lead Gilead Canada," Koomey said, "Now is a critical
time for pharma in Canada. As the
landscape for innovative medicines companies is shifting, we aim to
optimize patient access to innovative medicines in a sustainable
manner."
"Canada is such a critical market in Gilead's global operations,
and I am very pleased that Melissa will steward this next phase for
Gilead Canada," said Ertl. Koomey
succeeds Kennet Brysting, now Gilead Sciences' VP, Global
Commercial Strategy, HIV & Emerging Viruses, based on
Foster City, California. "Our
thanks go out to Kennet Brysting who made an important impact on
the business in Canada during his
tenure here," Ertl said.
About Gilead Sciences
Gilead Sciences,
Inc. is a research-based biopharmaceutical company that
discovers, develops and commercializes innovative medicines in
areas of unmet medical need. The company strives to transform and
simplify care for people with life-threatening illnesses around the
world. Gilead has operations in more than 35 countries worldwide,
with headquarters in Foster City, California. Gilead Sciences Canada, Inc. is
the Canadian affiliate of Gilead Sciences, Inc., and was
established in Mississauga,
Ontario in 2006.
SOURCE Gilead Sciences, Inc.